Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(2.30)
# 1,419
Out of 4,479 analysts
517
Total ratings
36.52%
Success rate
-0.7%
Average return
Main Sectors:
52 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESPR Esperion Therapeutics | Reiterates: Buy | $16 | $2.34 | +583.76% | 13 | Jun 28, 2024 | |
| IOVA Iovance Biotherapeutics | Reiterates: Buy | $32 | $8.06 | +297.02% | 24 | Jun 28, 2024 | |
| CALC CalciMedica | Reiterates: Buy | $20 | $4.25 | +370.59% | 5 | Jun 27, 2024 | |
| LGND Ligand Pharmaceuticals | Reiterates: Buy | $144 | $84.85 | +69.71% | 14 | Jun 27, 2024 | |
| RIGL Rigel Pharmaceuticals | Reiterates: Buy | $15 | $8.41 | +78.36% | 18 | Jun 25, 2024 | |
| BMEA Biomea Fusion | Reiterates: Buy | $15 | $4.42 | +239.37% | 15 | Jun 25, 2024 | |
| APRE Aprea Therapeutics | Reiterates: Buy | $20 | $4.03 | +396.28% | 9 | Jun 24, 2024 | |
| CKPT Checkpoint Therapeutics | Reiterates: Buy | $34 | $2.05 | +1,558.54% | 11 | Jun 24, 2024 | |
| PBLA Panbela Therapeutics | Reiterates: Neutral | n/a | $0.36 | - | 10 | Jun 24, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $90 | $55.32 | +62.69% | 16 | Jun 24, 2024 | |
| LXRX Lexicon Pharmaceuticals | Reiterates: Buy | $10 | $1.68 | +497.01% | 3 | Jun 24, 2024 | |
| CLNN Clene | Reiterates: Buy | $7 | $0.36 | +1,860.78% | 22 | Jun 21, 2024 | |
| PTN Palatin Technologies | Reiterates: Buy | $17 | $1.86 | +813.98% | 17 | Jun 20, 2024 | |
| TPST Tempest Therapeutics | Reiterates: Buy | $47 | $2.14 | +2,096.26% | 14 | Jun 20, 2024 | |
| STTK Shattuck Labs | Maintains: Buy | $28 → $16 | $3.99 | +301.00% | 13 | Jun 20, 2024 | |
| CYTK Cytokinetics | Reiterates: Buy | $90 | $54.70 | +64.53% | 25 | Jun 17, 2024 | |
| ATNM Actinium Pharmaceuticals | Reiterates: Buy | $50 | $7.20 | +594.44% | 19 | Jun 17, 2024 | |
| APTO Aptose Biosciences | Reiterates: Buy | $7 | $0.75 | +839.60% | 11 | Jun 14, 2024 | |
| LSTA Lisata Therapeutics | Reiterates: Buy | $15 | $3.55 | +322.54% | 10 | Jun 14, 2024 | |
| VYNE VYNE Therapeutics | Reiterates: Buy | $5.75 | $1.92 | +199.48% | 13 | Jun 14, 2024 | |
| PDSB PDS Biotechnology | Reiterates: Buy | $21 | $3.03 | +593.07% | 20 | Jun 12, 2024 | |
| BNOX Bionomics | Reiterates: Buy | $8 | $0.69 | +1,059.42% | 6 | Jun 12, 2024 | |
| CVKD Cadrenal Therapeutics | Reiterates: Buy | $3 | $0.46 | +545.72% | 4 | Jun 6, 2024 | |
| BLRX BioLineRx | Reiterates: Buy | $21 | $0.56 | +3,650.00% | 9 | Jun 3, 2024 | |
| CLDX Celldex Therapeutics | Reiterates: Buy | $80 | $38.99 | +105.18% | 20 | Jun 3, 2024 | |
| CMPX Compass Therapeutics | Reiterates: Buy | $10 | $0.95 | +957.64% | 9 | Jun 3, 2024 | |
| XOMA XOMA Corporation | Reiterates: Buy | $74 | $24.90 | +197.19% | 12 | May 31, 2024 | |
| PHAR Pharming Group | Reiterates: Buy | $37 | $8.05 | +359.63% | 6 | May 31, 2024 | |
| BCDA BioCardia | Reiterates: Buy | $60 | $2.99 | +1,906.69% | 10 | May 29, 2024 | |
| PHGE BiomX | Reiterates: Buy | $2 | $0.34 | +486.17% | 9 | May 21, 2024 | |
| BIOR Biora Therapeutics | Reiterates: Buy | $15 | $0.63 | +2,281.33% | 7 | May 16, 2024 | |
| MBIO Mustang Bio | Reiterates: Buy | $2 | $0.48 | +312.88% | 7 | May 16, 2024 | |
| TNYA Tenaya Therapeutics | Reiterates: Buy | $18 | $3.37 | +434.12% | 7 | May 15, 2024 | |
| KURA Kura Oncology | Reiterates: Buy | n/a | $21.20 | - | 16 | May 14, 2024 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $40 | $4.84 | +726.45% | 11 | May 14, 2024 | |
| GNTA Genenta Science | Reiterates: Buy | $25 | $3.08 | +710.90% | 3 | May 13, 2024 | |
| ATXS Astria Therapeutics | Reiterates: Buy | $16 | $9.25 | +72.97% | 10 | May 10, 2024 | |
| NVCT Nuvectis Pharma | Reiterates: Buy | $21 | $6.18 | +239.81% | 6 | May 8, 2024 | |
| KRYS Krystal Biotech | Reiterates: Buy | $200 | $182.27 | +9.73% | 18 | May 8, 2024 | |
| ARMP Armata Pharmaceuticals | Reiterates: Buy | $7 | $2.75 | +154.55% | 9 | May 8, 2024 | |
| LCTX Lineage Cell Therapeutics | Reiterates: Buy | $7 | $0.95 | +633.68% | 7 | May 6, 2024 | |
| OABI OmniAb | Reiterates: Buy | $11 | $3.74 | +194.12% | 4 | Mar 21, 2024 | |
| XBIO Xenetic Biosciences | Downgrades: Neutral | n/a | $4.17 | - | 4 | May 16, 2023 | |
| BYSI BeyondSpring | Downgrades: Neutral | n/a | $2.47 | - | 6 | Dec 1, 2021 | |
| EPIX ESSA Pharma | Maintains: Buy | $36 → $32 | $5.12 | +525.00% | 4 | Feb 25, 2021 | |
| SSKN STRATA Skin Sciences | Upgrades: Buy | $30 | $3.01 | +896.68% | 2 | Nov 3, 2020 | |
| CDMO Avid Bioservices | Reiterates: Buy | $11 → $9 | $7.12 | +26.40% | 2 | Mar 11, 2020 | |
| SNGX Soligenix | Downgrades: Neutral | n/a | $2.47 | - | 2 | Jan 31, 2018 | |
| TGTX TG Therapeutics | Assumes: Buy | $18 → $33 | $18.15 | +81.82% | 2 | Nov 14, 2017 | |
| FBIO Fortress Biotech | Initiates: Buy | $165 | $1.69 | +9,663.31% | 1 | Jul 11, 2017 | |
| PIRS Pieris Pharmaceuticals | Initiates: Buy | $720 | $9.70 | +7,322.68% | 1 | May 30, 2017 | |
| VSTM Verastem | Reiterates: Buy | $60 → $78 | $3.25 | +2,300.00% | 1 | Mar 24, 2017 |
Esperion Therapeutics
Jun 28, 2024
Reiterates: Buy
Price Target: $16
Current: $2.34
Upside: +583.76%
Iovance Biotherapeutics
Jun 28, 2024
Reiterates: Buy
Price Target: $32
Current: $8.06
Upside: +297.02%
CalciMedica
Jun 27, 2024
Reiterates: Buy
Price Target: $20
Current: $4.25
Upside: +370.59%
Ligand Pharmaceuticals
Jun 27, 2024
Reiterates: Buy
Price Target: $144
Current: $84.85
Upside: +69.71%
Rigel Pharmaceuticals
Jun 25, 2024
Reiterates: Buy
Price Target: $15
Current: $8.41
Upside: +78.36%
Biomea Fusion
Jun 25, 2024
Reiterates: Buy
Price Target: $15
Current: $4.42
Upside: +239.37%
Aprea Therapeutics
Jun 24, 2024
Reiterates: Buy
Price Target: $20
Current: $4.03
Upside: +396.28%
Checkpoint Therapeutics
Jun 24, 2024
Reiterates: Buy
Price Target: $34
Current: $2.05
Upside: +1,558.54%
Panbela Therapeutics
Jun 24, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.36
Upside: -
Viking Therapeutics
Jun 24, 2024
Reiterates: Buy
Price Target: $90
Current: $55.32
Upside: +62.69%
Lexicon Pharmaceuticals
Jun 24, 2024
Reiterates: Buy
Price Target: $10
Current: $1.68
Upside: +497.01%
Clene
Jun 21, 2024
Reiterates: Buy
Price Target: $7
Current: $0.36
Upside: +1,860.78%
Palatin Technologies
Jun 20, 2024
Reiterates: Buy
Price Target: $17
Current: $1.86
Upside: +813.98%
Tempest Therapeutics
Jun 20, 2024
Reiterates: Buy
Price Target: $47
Current: $2.14
Upside: +2,096.26%
Shattuck Labs
Jun 20, 2024
Maintains: Buy
Price Target: $28 → $16
Current: $3.99
Upside: +301.00%
Cytokinetics
Jun 17, 2024
Reiterates: Buy
Price Target: $90
Current: $54.70
Upside: +64.53%
Actinium Pharmaceuticals
Jun 17, 2024
Reiterates: Buy
Price Target: $50
Current: $7.20
Upside: +594.44%
Aptose Biosciences
Jun 14, 2024
Reiterates: Buy
Price Target: $7
Current: $0.75
Upside: +839.60%
Lisata Therapeutics
Jun 14, 2024
Reiterates: Buy
Price Target: $15
Current: $3.55
Upside: +322.54%
VYNE Therapeutics
Jun 14, 2024
Reiterates: Buy
Price Target: $5.75
Current: $1.92
Upside: +199.48%
PDS Biotechnology
Jun 12, 2024
Reiterates: Buy
Price Target: $21
Current: $3.03
Upside: +593.07%
Bionomics
Jun 12, 2024
Reiterates: Buy
Price Target: $8
Current: $0.69
Upside: +1,059.42%
Cadrenal Therapeutics
Jun 6, 2024
Reiterates: Buy
Price Target: $3
Current: $0.46
Upside: +545.72%
BioLineRx
Jun 3, 2024
Reiterates: Buy
Price Target: $21
Current: $0.56
Upside: +3,650.00%
Celldex Therapeutics
Jun 3, 2024
Reiterates: Buy
Price Target: $80
Current: $38.99
Upside: +105.18%
Compass Therapeutics
Jun 3, 2024
Reiterates: Buy
Price Target: $10
Current: $0.95
Upside: +957.64%
XOMA Corporation
May 31, 2024
Reiterates: Buy
Price Target: $74
Current: $24.90
Upside: +197.19%
Pharming Group
May 31, 2024
Reiterates: Buy
Price Target: $37
Current: $8.05
Upside: +359.63%
BioCardia
May 29, 2024
Reiterates: Buy
Price Target: $60
Current: $2.99
Upside: +1,906.69%
BiomX
May 21, 2024
Reiterates: Buy
Price Target: $2
Current: $0.34
Upside: +486.17%
Biora Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $15
Current: $0.63
Upside: +2,281.33%
Mustang Bio
May 16, 2024
Reiterates: Buy
Price Target: $2
Current: $0.48
Upside: +312.88%
Tenaya Therapeutics
May 15, 2024
Reiterates: Buy
Price Target: $18
Current: $3.37
Upside: +434.12%
Kura Oncology
May 14, 2024
Reiterates: Buy
Price Target: n/a
Current: $21.20
Upside: -
Capricor Therapeutics
May 14, 2024
Reiterates: Buy
Price Target: $40
Current: $4.84
Upside: +726.45%
Genenta Science
May 13, 2024
Reiterates: Buy
Price Target: $25
Current: $3.08
Upside: +710.90%
Astria Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $16
Current: $9.25
Upside: +72.97%
Nuvectis Pharma
May 8, 2024
Reiterates: Buy
Price Target: $21
Current: $6.18
Upside: +239.81%
Krystal Biotech
May 8, 2024
Reiterates: Buy
Price Target: $200
Current: $182.27
Upside: +9.73%
Armata Pharmaceuticals
May 8, 2024
Reiterates: Buy
Price Target: $7
Current: $2.75
Upside: +154.55%
Lineage Cell Therapeutics
May 6, 2024
Reiterates: Buy
Price Target: $7
Current: $0.95
Upside: +633.68%
OmniAb
Mar 21, 2024
Reiterates: Buy
Price Target: $11
Current: $3.74
Upside: +194.12%
Xenetic Biosciences
May 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.17
Upside: -
BeyondSpring
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.47
Upside: -
ESSA Pharma
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $5.12
Upside: +525.00%
STRATA Skin Sciences
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $3.01
Upside: +896.68%
Avid Bioservices
Mar 11, 2020
Reiterates: Buy
Price Target: $11 → $9
Current: $7.12
Upside: +26.40%
Soligenix
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.47
Upside: -
TG Therapeutics
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $18.15
Upside: +81.82%
Fortress Biotech
Jul 11, 2017
Initiates: Buy
Price Target: $165
Current: $1.69
Upside: +9,663.31%
Pieris Pharmaceuticals
May 30, 2017
Initiates: Buy
Price Target: $720
Current: $9.70
Upside: +7,322.68%
Verastem
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $3.25
Upside: +2,300.00%